Cornichon-2 and cornichon-3 (CNIH-2/-3) are AMPA receptor (AMPAR) binding proteins that promote receptor trafficking and markedly slow AMPAR deactivation in heterologous cells, but their role in neurons is unclear. Using CNIH-2 and CNIH-3 conditional knockout mice, we find a profound reduction of AMPAR synaptic transmission in the hippocampus. This deficit is due to the selective loss of surface GluA1-containing AMPARs (GluA1A2 heteromers), leaving a small residual pool of synaptic GluA2A3 heteromers. The kinetics of AMPARs in neurons lacking CNIH-2/-3 are faster than those in WT neurons due to the fast kinetics of GluA2A3 heteromers. The remarkably selective effect of CNIHs on the GluA1 subunit is probably mediated by TARP g-8, which prevents a functional association of CNIHs with non-GluA1 subunits. These results point to a sophisticated interplay between CNIHs and g-8 that dictates subunit-specific AMPAR trafficking and the strength and kinetics of synaptic AMPAR-mediated transmission.
INTRODUCTION
It is well established that auxiliary proteins play a critical role in the trafficking and function of voltage-gated ion channels. However, until recently, it was thought that ionotropic neurotransmitter receptors operated independently of auxiliary subunits. This view changed with the discovery of the tetraspanning membrane protein stargazin, the protein that is mutated in the ataxic mouse stargazer. Cerebellar granule neurons (CGNs), in which stargazin is highly expressed, lack surface AMPA-type glutamate receptors (AMPARs) in the stargazer mouse. In addition to controlling AMPAR trafficking, stargazin also controls AMPAR gating, thus establishing it as a bona fide AMPAR auxiliary subunit. Stargazin is a member of a family of proteins termed transmembrane AMPAR regulatory proteins (TARPs), which have both distinct and overlapping properties to stargazin (Coombs and Cull-Candy, 2009; Díaz, 2010; Jackson and Nicoll, 2011; Kato et al., 2010b; Straub and Tomita, 2012) . Additional AMPAR auxiliary subunits, unrelated to TARPs, have been identified from a variety of screens (Wang et al., 2008; Zheng et al., 2004) . Among these proteins are cornichon-2 and cornichon-3 (CNIH-2 and CNIH-3, respectively) (Schwenk et al., 2009 ). In expression systems, CNIH-2 markedly slows AMPAR deactivation and desensitization and shares a number of other properties with TARPs (Gill et al., 2011 (Gill et al., , 2012 Harmel et al., 2012; Kato et al., 2010a; Schwenk et al., 2009; Shi et al., 2010) . However, in CGNs and hippocampal neurons, no significant effect of CNIH-2 overexpression was observed on AMPAR-mediated synaptic currents (Shi et al., 2010) . Thus, it was proposed that CNIH-2's function in neurons was more akin to its yeast and Drosophila homologs, which serve as chaperones in the forward trafficking of EGFR ligands from ER to Golgi (Bö kel et al., 2006; Castillon et al., 2009) . Additional studies on CNIH-2 supported its role in forward trafficking of neuronal AMPARs (Harmel et al., 2012) but concluded that CNIH-2 remained bound to AMPARs on the surface of neurons (Gill et al., 2011; Harmel et al., 2012; Kato et al., 2010a) . Furthermore, it was proposed that CNIH-2 displaced g-8, the primary TARP expressed in the hippocampus, thus reducing TARP stoichiometry (Gill et al., 2011 (Gill et al., , 2012 Kato et al., 2010a) , which challenged previous work suggesting that all possible g-8 binding sites on native AMPARs were occupied .
In the present study, we have generated conditional CNIH-2 and CNIH-3 knockout (KO) mice to determine the roles of CNIH-2 and CNIH-3 in excitatory synaptic transmission in the hippocampus. We find that CNIHs play a critical role in supporting AMPAR-mediated responses, because AMPAR function is profoundly reduced in neurons lacking both CNIH-2 and CNIH-3. However, importantly, CNIH-2/-3 binding to AMPARs is dependent on AMPAR subunit composition and TARPs. Four subunits (GluA1-GluA4) contribute to the formation of tetrameric AMPARs. We have previously shown that $80% of synaptic AMPARs in CA1 pyramidal neurons are composed of GluA1A2 heteromers, whereas the rest are GluA2A3 heteromers . Here, our data reveal that CNIH-2/-3 selectively bind to GluA1 in hippocampal neurons, allowing GluA1A2 receptors to reach the surface, and suggest that CNIH-2/-3 interaction with non-GluA1 subunits is prevented by g-8. Removal of CNIH-2/-3 also speeds up the deactivation kinetics of surface AMPARs, an effect attributable to the loss of GluA1A2 receptors, which deactivate more slowly than GluA2A3 receptors. Thus, our data point to a model in which the trafficking and gating of individual AMPARs are determined by the interplay of AMPAR subunits, cornichons, and TARPs. ) mice, in which CNIH-2 is deleted from all forebrain pyramidal neurons, appeared grossly normal, and breeding was Mendelian.
RESULTS

Genetic Deletion of CNIH-2 and CNIH-3
Deletion of CNIH-2 Selectively Depresses AMPAR Synaptic Transmission
We used three strategies to study the effects of deleting CNIH-2. Using Cnih2 fl/fl mice, we (1) injected AAV-CRE-GFP into the hippocampus of postnatal day 0-2 (P0-P2) mouse pups and then made acute slices 3 weeks later; (2) made hippocampal slice cultures at P6-P9, biolistically transfected neurons with CRE-GFP at 4 days in vitro (DIV), and recorded 2-3 weeks later (see Experimental Procedures for details); and (3) crossed Cnih2 fl/fl mice with the NEX-CRE mouse line. In the first two sets of experiments, simultaneous recordings of AMPAR-and NMDAR-evoked excitatory postsynaptic currents (AMPAR-and NMDAR-eEPSCs, respectively) were made from a green-infected/-transfected CA1 pyramidal neuron expressing CRE and a neighboring control nongreen pyramidal neuron during stimulation of excitatory axons in stratum radiatum. This approach permitted a pairwise, internally controlled comparison of the consequence of our genetic manipulation. In the third approach using acute slices prepared from NexCnih2 À/À mice, the ratio of the AMPARand NMDAR-eEPSCs was calculated and compared to wildtype neurons. CNIH-2 deletion in single neurons by P0-P2 injection (red circles) and in slice culture (black circles) caused a 54% reduction in AMPAR-eEPSCs ( Figure 1A ), but no change in NMDAR-eEPSCs ( Figure 1B ). Because there was no significant difference between the results from acute and cultured slices, the data were combined. CNIH-2 deletion also caused a speeding in the decay of AMPAR-EPSCs in acute slices. This included eEPSCs ( Figure 1C ) and miniature EPSCs (mEPSCs) ( Figure 1E ). Furthermore, mEPSC amplitude was reduced (Figure 1D ), consistent with a reduction in AMPAR number at individual synapses. The difference in the magnitude of amplitude change between the evoked and mEPSCs can be explained by the fact that a threshold is required for detecting mEPSCs, and many events fall below this threshold in the absence of CNIH-2. This is reflected in the large decrease in mEPSC frequency ( Figure S2A ). To quantitatively determine the effects of CNIH-2 on AMPAR kinetics, we pulled somatic outside-out patches and used ultrafast glutamate application to measure AMPAR deactivation ( Figure 1F ) and desensitization ( Figure 1G ). Both desensitization and deactivation time constants were faster in the absence of CNIH-2. We also examined AMPAR currents generated from somatic extrasynaptic outside-out patches in the presence of cyclothiazide to block desensitization. Similar to AMPAR-eEPSCs, extrasynaptic currents were reduced by 47% in CRE-infected neurons ( Figure 1H ). Furthermore, if CNIH-2 reduces the stoichiometry of TARP g-8 binding to AMPARs as previously proposed by Gill et al. (2011) and Kato et al. (2010a) , then in the absence of CNIH-2, the g-8/AMPAR stoichiometry should increase, and thus, the kainate/glutamate (I KA /I Glu ) ratio, a sensitive assay for g-8/AMPAR stoichiometry , should also increase. However, no change in I KA /I Glu was seen in neurons lacking CNIH-2 ( Figure 1I ). We also observed no change in AMPAR-eEPSC rectification in the absence of CNIH-2, indicating no change in GluA2 content (Figure S2B) . CNIH-2 deletion also failed to influence paired-pulse ratio, indicating an exclusively postsynaptic role for CNIH-2 ( Figure S2C ).
Deletion of CNIH-3 Selectively Depresses AMPAR Synaptic Transmission when Combined with CNIH-2 Deletion CNIH-3 is also expressed in hippocampus, although at a lower level than CNIH-2 (Lein et al., 2007) . We therefore analyzed Cnih3 fl/fl mice (Figures S1B and S1C). We found that deleting CNIH-3 had no effect on AMPAR-or NMDAR-eEPSCs (Figures 2A and 2B) , suggesting that either CNIH-3 is not expressed in these neurons or that an excess of CNIH-2 compensates for the loss of CNIH-3. To distinguish between these alternatives, we generated Cnih2/3 fl/fl mice. Deletion of both CNIH-2 and CNIH-3 resulted in a profound and selective reduction in the AMPAR-eEPSC, significantly greater than that seen with CNIH-2 deletion alone ( Figures 2C-2F ). These results suggest that CNIH-2 can compensate for the lack of CNIH-3, CNIH-2 is the dominant of the two isoforms, and CNIH-2 and CNIH-3 are both essential for synaptic AMPAR expression in the hippocampus. Deletion of CNIH-2 and CNIH-3 also reduced mEPSC amplitude by $20% (Figure 2G ), similar to that observed with CNIH-2 elimination ( Figure 2I ), whereas mEPSC decay was faster than elimination of CNIH-2 alone (Figures 2H and 2J) . In Figures 2E, 2F , 2I, and 2J, our CNIH KO results are summarized and compared to previous results obtained by the conditional KO of GluA1 . Strikingly, the effects of CNIH-2/-3 elimination on the AMPAR-eEPSC, mEPSC amplitude, and kinetics are indistinguishable from the effects of deleting GluA1. Interestingly, previous studies on the germline GluA1 KO mouse (Andrá sfalvy et al., 2003; Zamanillo et al., 1999) did not report a speeding of mEPSCs. We repeated these experiments, however, and observed the same speeding as we found in the conditional GluA1 KO neurons ( Figure S3 ). We have no clear explanation for the difference, although Andrá sfalvy et al. (2003) did report faster deactivation in outside-out patches from the germline KO mouse. Long-term potentiation (LTP), which is widely held as the cellular basis for learning and memory, is also found to be severely reduced in hippocampal neurons from GluA1 KO mice (Zamanillo et al., 1999) . We, therefore, examined LTP in neurons lacking CNIH-2/-3. If GluA1-containing AMPARs are removed from synapses in the absence of CNIH-2/-3, LTP should be compromised. Indeed, when compared to uninfected neurons, LTP was markedly reduced in Cnih2/3 fl/fl neurons infected with CRE ( Figure 2K ). Thus, knocking out CNIH-2/-3 appeared to phenocopy knocking out GluA1 in three key parameters. Previous studies in HEK cells (Kato et al., 2010a) suggested that the absence of CNIH proteins in neurons should result in AMPAR resensitization and alterations in cyclothiazide potentiation of kainate-induced currents. However, neither of these effects was observed ( Figures S3C  and S3D ). (F and G) Bar graphs show mean ± SEM AMPAR deactivation (F, Ctl, 3.6 ± 0.2 ms; n = 12; DCNIH-2, 2.7 ± 0.2 ms; n = 18; *p < 0.002) and desensitization (G, Ctl, 13.2 ± 0.8 ms; n = 14; DCNIH-2, 8.7 ± 0.4 ms; n = 19; *p < 0.0001) from outside-out patches pulled from Ctl and CRE-infected cells and exposed to 1 and 100 ms applications of 1 mM glutamate, respectively. Peak-normalized sample traces are shown to the left.
(H) Bar graph shows mean ± SEM 1 mM glutamateinduced current amplitudes from outside-out patches pulled from Ctl and CRE-infected cells (Ctl, 870 ± 148 pA; n = 12; DCNIH-2, 458 ± 46 pA; n = 17; *p < 0.01). Sample traces are shown to the left.
(I) Bar graph shows mean ± SEM I KA /I Glu ratios from outside-out patches pulled from Ctl and CRE-infected cells that were exposed to 1 mM glutamate and 1 mM kainate (Ctl, 0.54 ± 0.03; n = 5; DCNIH-2, 0.51 ± 0.03; n = 12; p = 0.56). Sample traces are shown to the left. See also Figure S2 .
GluA1 Is Required for the Effect of CNIH-2
We next directly tested whether the effects of deleting CNIH-2/-3 are specifically related to the regulation of GluA1. To this end, we compared the effects of CNIH-2 knockdown (KD) on AMPAReEPSCs in GluA1 and GluA2 KO mice. The shRNA we generated was highly effective in knocking down CNIH-2 protein levels (Figure S4A ) and in wild-type neurons produced a phenotype identical to knocking out CNIH-2 ( Figures 1A, 1B , 3A, and 3B). The KD of CNIH-2 in neurons from GluA2 KO mice, which primarily express GluA1 homomers, also resulted in a selective but more pronounced reduction in the AMPAR-eEPSC compared to wild-type mice ( Figures 3C, 3D , 3G, and 3H). In striking contrast, CNIH-2 KD in slices from GluA1 KO mice had no effect on AMPAR-eEPSCs ( Figure 3E ), AMPAR mEPSC kinetics ( Figure S4B ), or NMDAR eEPSCs ( Figure 3F ), demonstrating that CNIH-2 effects on synaptic AMPARs require GluA1. The eEPSC results are summarized in Figures 3G and 3H . Additionally, residual GluA2A3 receptors in GluA1 KO neurons were found to have a I KA /I Glu ratio of $0.5, suggesting that all available TARP binding sites on these receptors are occupied ( Figure S4C ). Although it is well established that CNIH-2 binds to AMPARs (Kato et al., 2010a; Schwenk et al., 2009; Shi et al., 2010) , the relative binding to GluA subunits has not been reported. Because CNIH-2 KD has a profound and selective effect on GluA1-containing AMPARs, we compared GluA1 and GluA2 binding to CNIH-2. We first immunoprecipitated GluA2 from wild-type hippocampal lysates using two different antibodies (anti-GluA2 or anti-GluA2/3). We found that CNIH-2 coimmunoprecipitated with GluA2 from wild-type hippocampal lysates, as expected ( Figure 3I ). In sharp contrast, we observed no coimmunoprecipitation of CNIH-2 with GluA2 when using GluA1 KO lysates. (A-F) Scatterplots show amplitudes of AMPAR and NMDAR-eEPSCs of Ctl and CNIH-2 shRNA-transfected neurons in cultured slices from wild-type, GluA2 KO, and GluA1 KO mice. Filled circles show mean ± SEM. Distributions show that the CNIH-2 shRNA reduces the amplitude of AMPAR-eEPSCs in wild-type (WT) (A, WT, 102.5 ± 16.5 pA; WT + CNIH-2 shRNA, 52.0 ± 8.6 pA; n = 11; *p < 0.05) and GluA2 KO mice (C, GluA2 KO, 128.9 ± 18.2 pA; GluA2 KO + CNIH-2 shRNA, 40.2 ± 5.1 pA; n = 10; *p < 0.05), but not GluA1 KO mice (E, GluA1 KO, 54.8 ± 13.1 pA; GluA1 KO + CNIH-2 shRNA, 58.1 ± 12.3 pA; n = 9; p = 0.4). No effects were seen on NMDAR-eEPSCs (B, WT, 44.3 ± 7.0 pA; WT + CNIH-2 shRNA, 42.0 ± 4.5 pA; n = 10; p = 1; D, GluA2 KO, 39.4 ± 5.1 pA; GluA2 KO + CNIH-2 shRNA, 34.9 ± 7.4 pA; n = 9; p = 0.4; F, GluA1 KO, 84.9 ± 18.1 pA; GluA1 KO + CNIH-2 shRNA, 79.5 ± 23.3 pA; n = 8; p = 0.8). Insets show sample current traces. Bar graphs to the right show mean ± SEM AMPAR and NMDAR-eEPSC amplitudes presented in scatterplots.
AMPA eEPSC Summary
(G and H) Bar graphs normalized to Ctl summarizing mean ± SEM AMPAR and NMDAR-eEPSC data from CNIH-2 shRNA transfection of wild-type, GluA2 KO, and GluA1 KO mice. (I) Immunoprecipitation (IP) of GluA2, GluA1, and CNIH-2 from hippocampal lysates of one wild-type mouse and two GluA1 KO mice using antibodies against GluA2 and GluA2/3. See also Figure S4 .
However, CNIH-2 coimmunoprecipitated with GluA1 from GluA2 KO lysates (Figure S8B) , and g-8 was coimmunoprecipitated with GluA2 from both wild-type and GluA1 KO lysates ( Figure S4D) . These biochemical studies demonstrate a striking specificity of CNIH-2 binding to GluA1 subunits in the hippocampus. Together, these data indicate that both the physical and functional interactions of CNIH-2 with native AMPARs require the GluA1 subunit.
To evaluate the surface expression of GluA1 using immunofluorescence microscopy, we cultured dissociated rat hippocampal neurons transfected with CNIH-2 shRNA and visualized somatic and dendritic surface GluA1 immunoreactivity $20 days later. CNIH-2 shRNAtransfected neurons were compared to adjacent untransfected neurons. CNIH-2 KD dramatically reduced surface GluA1 ( Figures 4A and S5A) , consistent with our findings showing reduction of synaptic currents. Transfection of a scrambled shRNA or GFP alone had no effect on surface GluA1 staining ( Figures 4B, S5B , and S5C).
Our data, thus far, demonstrate that synaptic expression of GluA1A2 AMPARs is eliminated in the absence of CNIH-2/-3.
What then accounts for the fast kinetics of the remaining AMPARs observed after deleting CNIH-2/-3? Importantly, deletion of GluA1 results in the same fast kinetics, suggesting that (D) Bar graph showing mean ± SEM deactivation of GluA1A2g-8 and GluA2A3g-8 complexes and the change in AMPAR deactivation kinetics in outsideout patches from DCNIH-2 and DCNIH-2/-3 CA1 pyramidal neurons: GluA1A2 + g-8, 3.9 ± 0.4 ms (n = 10); GluA2A3 + g-8, 1.8 ± 0.2 ms (n = 10), p < 0.001; wild-type, 3.6 ± 0.2 ms (n = 12); DCNIH-2, 2.7 ± 0.2 ms (n = 18), *p < 0.002; and DCNIH-2/-3, 1.6 ± 0.2 ms (n = 6), *p < 0.0001. (E) Bar graph showing mean ± SEM deactivation of GluA2A3g-8 complexes normalized to GluA1A2g-8 complexes in outside-out patches from HEK cells (Glu) compared to the percent change in mEPSC decay (mEPSC) in DCNIH-2/-3 and DGluA1 CA1 pyramidal neurons (*p < 0.001). See also Figure S5 .
the kinetics are a direct result of the specific molecular composition of the remaining receptors, which are primarily GluA2A3g-8 complexes ). Therefore, we next used heterologous cells to evaluate whether CNIH-2 affects AMPAR kinetics by specifically regulating GluA1A2 trafficking. We coexpressed GluA2, GluA3, and g-8 in HEK cells and measured the deactivation of this receptor complex ( Figures 4C-4E ). For all experiments, flip-type AMPAR subunits were evaluated (see Supplemental Experimental Procedures). GluA2A3g-8 complex deactivation is twice as fast as GluA1A2g-8, with GluA2A3g-8 deactivation being virtually identical to the deactivation of AMPARs in CRE-expressing Cnih2/3 fl/fl neurons ( Figure 4D ). Furthermore, the difference in deactivation between GluA1A2g-8 and GluA2A3g-8 complexes is virtually identical to the magnitude of change in mEPSC decay in both CRE-expressing conditional GluA1 and CNIH-2/-3 (Gria1 fl/fl and Cnih2/3 fl/fl ) KO neurons ( Figure 4E ).
Thus, these findings indicate that the kinetic changes caused by the deletion of CNIH-2/-3 in neurons can be fully explained by the selective removal of the GluA1 subunit, leaving GluA2A3g-8 complexes with faster kinetics.
Effect of CNIH-2 Deletion on Synaptic Proteins
The lack of synaptic GluA1-containing AMPARs in the absence of CNIH-2/-3 expression may be explained by either a selective loss in total GluA1 protein expression or a specific involvement of CNIH proteins in the forward trafficking of GluA1-containing AMPARs to synapses. To examine potential effects of CNIH-2 on synaptic protein expression, Cnih2 fl/fl mice were crossed to the Nex-CRE mouse line to create NexCnih2 À/À mice. CRE expression in these mice includes pyramidal neurons of the neocortex and hippocampus as well as mossy and granule cells in the dentate gyrus (Goebbels et al., 2006) . We first used AMPA/NMDA ratios to ensure that similar synaptic defects were present in the hippocampus of NexCnih2 À/À mice. Because CNIH-2 has no effect on NMDAReEPSCs, a change in this ratio should be an accurate reflection of synaptic AMPAR content. AMPA/NMDA ratios were reduced by half in CA1 pyramidal neurons lacking CNIH-2 ( Figure 5A ). We also observed similar reductions in dentate granule neurons and layer 2/3 pyramidal neurons in barrel cortex ( Figure 5A ). Interestingly, no change in the ratio was found in the heterozygous (NexCnih2
) mice ( Figure 5A ) despite a 30%-50% reduction in total CNIH-2 expression ( Figure S6A ), thus providing further evidence that CNIH-2 is expressed in excess in CA1 pyramidal neurons and that all available CNIH-2 binding sites on AMPARs are occupied or ''saturated.'' In paired recordings from slice cultures from NexCnih2 À/À mice, transfection of CA1 pyramidal neurons with CNIH-2 fully rescued AMPAR-eEPSCs ( Figure 5B ). No change in the NMDAR-eEPSC was observed ( Figure 5C ). As previously shown, CNIH-2 overexpression in wild-type neurons has no effect on AMPAR-or NMDAR-eEPSCs ( Figures S6B and S6C ) (Shi et al., 2010) , again indicating saturation of CNIH binding sites on native AMPARs. We next examined the total expression level of a number of synaptic proteins in NexCnih2 À/À mice. Importantly, no CNIH-2 protein was detected in hippocampal lysates, confirming that CNIH-2 is absent in the hippocampus of these mice ( Figures  5D and 5E ). We found that GluA1 and GluA2 were reduced by about 15%, but no change was observed for g-8, PSD-95, or the NMDAR subunit GluN2A ( Figure 5D ). Infection of dissociated hippocampal neurons with the CNIH-2 shRNA also produced little effect on total GluA1 and GluA2 expression levels (Figure S4A) . We then compared the consequences of deleting CNIH-2 to g-8 deletion ( Figure 5E ). Total expression of GluA1 and GluA2 is more severely reduced in g-8 KO mice than in NexCnih2 À/À mice, and unlike the lack of change in g-8 levels in NexCnih2 À/À mice, total CNIH-2 expression is markedly reduced in g-8 KO mice, as reported previously by Kato et al. (2010a) . Because the modest loss of AMPAR protein in the absence of CNIH-2 expression is unlikely to explain the profound effects on physiology, we next examined the effect of deleting CNIH-2 on AMPAR trafficking to the cell surface. AMPARs are glycoproteins, which traffic through the biosynthetic pathway. To determine whether CNIH-2 affects AMPAR maturation, we examined receptor glycosylation using endoglycosidase H (Endo H), which digests immature high-mannose sugars, and PNGase F, which removes all N-linked carbohydrates. Relative to wild-type brains, both GluA1 and GluA2 showed increased sensitivity to Endo H in NexCnih2
À/À brains ( Figures 5F and S6D) , as demonstrated by stronger Endo H-sensitive immature bands (red arrows) compared to Endo H-resistant mature bands (blue arrows). These data suggest that a large pool of immature receptors is retained in the ER or cis-Golgi in the absence of CNIH-2. The Endo H-sensitive band comigrates with completely deglycosylated receptors following treatment with PNGase F. We also reexamined the distribution of CNIH-2 protein in the hippocampus, using an antibody we recently generated using the same epitope as Kato et al. (2010a) . As in our previous study (Shi et al., 2010) , the large majority of CNIH-2 was intracellular. However, with this alternative antibody, CNIH-2 could also be detected on the cell surface ( Figure 5G ).
TARP g-8 Reverses the CNIH-2-Induced Slowing of GluA2-Containing AMPARs, but Not Homomeric GluA1 Receptors In heterologous cells, CNIH-2 has marked effects on GluA1-containing and -lacking AMPARs (Schwenk et al., 2009) . What then accounts for the selective effects of CNIH-2 deletion on native GluA1-containing receptors? Furthermore, how can one reconcile the fact that all CNIH binding sites appear to be occupied in CA1 neurons, and yet endogenous AMPAR kinetics are considerably faster than the kinetics of AMPARs coexpressed with CNIH-2 in expression systems? To better understand the AMPAR kinetics in expression systems, we examined a variety of conditions. Initially, we measured the effects of CNIH-2 and g-8, the primary TARP in the hippocampus (Rouach et al., 2005) , on receptors of defined subunit composition in HEK cells. As seen previously, CNIH-2 significantly slowed deactivation of GluA1 homomeric receptors and to a greater extent than g-8 (Figure 6Ai ). Expression of both CNIH-2 and g-8 did not significantly change the slowing seen with CNIH-2 alone (Figure 6Ai) . These findings could be explained by CNIH-2 and g-8 binding to the same site on GluA1 subunits with CNIH-2 displacing g-8 or the two proteins binding to separate sites. The fact that the slowing of kinetics seen with CNIH-2 is the same in GluA1-containing AMPARs with covalently attached g-8 (Shi et al., 2010) suggests that CNIH-2 is not displacing g-8. Furthermore, the fact that the I KA /I Glu ratio, a sensitive measure of g-8/AMPAR stoichiometry, is unchanged (Figure 6Aii ) also strongly argues that CNIH-2 is not displacing g-8 and that g-8 and CNIH-2 are able to co-occupy GluA1 subunits. These results, however, do not explain why CNIH-2 appears to occupy all available binding sites on neuronal AMPARs, and yet native neuronal AMPAR kinetics are substantially faster than what is observed when CNIH-2 and g-8 are expressed with homomeric GluA1. Might GluA2 behave differently from GluA1, in that essentially all native AMPARs in CA1 pyramidal neurons contain the GluA2 subunit )? We therefore examined the effect of CNIH-2 on GluA2 homomers in HEK cells. Unedited GluA2(Q) was used owing to its ability to form functional channels at higher levels than GluA2(R). Like GluA1, we found that CNIH-2 slowed deactivation of GluA2 homomers (Figures 6B). However, in sharp contrast to GluA1, the coexpression of g-8 reversed the slowing of homomeric GluA2 kinetics caused by CNIH-2 ( Figure 6B ). The I KA /I Glu ratio of GluA2(Q) in the presence of both g-8 and CNIH-2 was 0.48 ± 0.04 (n = 6), indicating a four g-8 receptor ( Figure S7 ). We repeated the experiments with GluA1A2(R) heteromers, the subunit composition that accounts for the majority of endogenous AMPARs in CA1 neurons ). When GluA1A2 heteromers were coexpressed with either g-8 or CNIH-2, CNIH-2 produced a much stronger slowing of deactivation compared to g-8, as expected. Remarkably, however, coexpression of g-8 and CNIH-2 with GluA1A2 heteromers reversed CNIH-2-induced slowing ( Figure 6C ). Together, these findings are of considerable interest for two main reasons. One, such data are consistent with a model in which g-8 prevents the physical interaction of CNIH with non-GluA1 subunits, thus explaining the observed CNIH subunit specificity. And two, when CNIH-2 is bound to GluA1 but prevented from functionally interacting with tative blot to the left shows the relative amount of mature GluA1 receptor subunits (blue arrows) to immature GluA1 subunits (red arrows) in hippocampal lysates from wild-type and NexCnih2 À/À mice. Bar graph to the right shows the average ratio ± SEM of immature to mature GluA1 and GluA2 subunits in NexCnih2 À/À mice normalized to wild-type mice: GluA1, 1.99 ± 0.28; and GluA2, 1.70 ± 0.13 (n = 3-5), *p < 0.05.
(G) Biotinylation analysis of GluA1, GluA2, g-8, and CNIH-2 in dissociated hippocampal neurons. See also Figure S6 .
GluA2 by g-8, as would be expected in neurons, CNIH-2 has little influence on the kinetics of GluA1A2 heteromers. It is important to note that previous efforts to understand CNIH function have focused heavily on whether or not CNIH proteins are associated with synaptic AMPARs or sequestered in the ER. The present data appear to diminish the relevance of this issue owing to the fact that all of the physiological consequences of deleting CNIH proteins can be explained by the selective loss of synaptic GluA1A2 heteromers. Based on the results in Figure 6Ai , one might expect the kinetics of the AMPAR EPSC to be slow in pyramidal neurons from GluA2 KO mice, because most receptors are composed of GluA1 homomers , presumably bound to CNIH-2/-3. This, however, is not the case . Surprisingly, we find a marked enhancement in the total expression and association of g-2 with GluA1-containing receptors when GluA2 expression is reduced ( Figures S8A and S8B ). g-2 has been shown to reverse the kinetic effects of CNIH-2/-3 on GluA1 homomers (Gill et al., 2012;  Figure S8C ). Indeed, in neurons from stargazer mice (a g-2-deficient mouse line), GluA2 KD leads to slowing of AMPA mEPSC decay kinetics as expected ( Figures S8D and S8E ). See Figure S8 for more details.
CNIH-2 Enhances AMPAR-Mediated Responses in the g-8 KO
The aforementioned results provide an explanation for the paradox that, whereas all CNIH-2 binding sites of native AMPARs seem to be occupied, the kinetics of neuronal AMPARs are fast. That is, under normal conditions, g-8 prevents a functional association of CNIH-2/-3 to GluA2 and thus prevents the expected slowing of GluA1A2 heteromers. If this model is correct and CNIH proteins are able to associate with AMPARs on the surface, then deleting g-8 should cause a marked slowing in mEPSCs. However, whereas we confirmed a reduction in mEPSC amplitude in g-8 KO mice (Figure 7A ), no effect on mEPSC decay was observed ( Figure 7B ) (Rouach et al., 2005) . One explanation for this might be that CNIH-2 is expressed at severely reduced levels in g-8 KO mice ( Figure 5E ) (Kato et al., 2010a) . Therefore, we expressed CNIH-2 in slice cultures made from g-8 KO mice and found that CNIH-2 not only rescued the amplitude of the AMPAR-mEPSCs ( Figure 7A ) but also markedly slowed mEPSC responses, such that the kinetics were considerably slower than what is seen in wild-type neurons or when CNIH-2 is overexpressed in wild-type neurons ( Figure 7B ). These data are compelling for several reasons. One, they show that CNIH-2 effects on AMPAR kinetics are similar in HEK cells and in neurons lacking g-8. Two, they emphasize the critical role that g-8 has in determining the effects of CNIH-2/-3 on AMPAR kinetics. And three, they demonstrate that CNIH proteins are able to associate with synaptic AMPARs. Although we maintain that the primary role for CNIH proteins is in the selective trafficking of GluA1A2 heteromers to synapses, the presence of CNIH protein on the surface of neurons ( Figure 5G ) and the ability of CNIH-2 to influence gating properties of synaptic AMPARs in the absence of g-8 ( Figure 7B ) are consistent with a selective and likely inert association of CNIH protein with GluA1 subunits of native synaptic GluA1A2 heteromers in the presence of g-8.
DISCUSSION
In this study, we used a variety of approaches, including the generation of conditional KO mice for CNIH-2 and CNIH-3, to determine the role of cornichon proteins in the regulation of neuronal AMPARs. By deleting CNIHs from neurons, we reveal a critical role for these proteins in regulating AMPAR-mediated synaptic transmission because there is a profound loss of AMPAR currents in KO neurons. We have demonstrated that under native conditions, CNIH is saturating, and the KD or KO of CNIHs is essential for studying their roles in neurons. (A) Bar graph shows mean ± SEM deactivation kinetics of GluA1 homomers expressed in HEK cells alone, with g-8, with CNIH-2, and with g-8 and CNIH-2: (Ai), GluA1, 1.8 ± 0.2 ms (n = 10); GluA1 + g-8, 4.9 ± 0.3 ms (n = 8); GluA1 + CNIH-2, 8.7 ± 0.6 ms (n = 11); and GluA1 + g-8 + CNIH-2, 9.4 ± 0.7 ms (n = 12). Mean ± SEM I KA /I Glu ratios for GluA1 + g-8 and GluA1 + g-8 + CNIH-2 were also compared: (Aii), GluA1 + g-8, 0.57 ± 0.03 (n = 8); and GluA1 + g-8 + CNIH-2, 0.54 ± 0.05 (n = 5).
(B and C) Bar graphs show mean ± SEM deactivation kinetics of GluA2(Q) homomers and GluA1A2(R) heteromers expressed in HEK cells alone, with g-8, with CNIH-2, and with g-8 and CNIH-2: (B), GluA2(Q), 1.2 ± 0.2 ms (n = 8); GluA2(Q) + g-8, 4.5 ± 1.0 ms (n = 4); GluA2(Q) + CNIH-2, 10.0 ± 1.5 ms (n = 7); and GluA2(Q) + g-8 + CNIH-2, 6.0 ± 0.7 ms (n = 6); and (C), GluA1A2(R), 1.7 ± 0.4 ms (n = 6); GluA1A2(R) + g-8, 3.9 ± 0.4 ms (n = 10); GluA1A2(R) + CNIH-2, 11.7 ± 1.0 ms (n = 6); and GluA1A2(R) + g-8 + CNIH-2, 5.7 ± 0.5 ms (n = 9), *p < 0.05. Corresponding peak-normalized sample traces are shown to the left of bar graphs. See also Figure S7 .
Furthermore, we find an unanticipated subunit specificity, in that CNIH-2/-3 preferentially interact with and functionally regulate GluA1-containing AMPARs. Strikingly, CNIH-2/-3 KO neurons phenocopy GluA1 KO neurons with respect to their current amplitudes, kinetics, and synaptic plasticity. All of our findings are most consistent with a model in which the primary role of CNIH-2/-3 in CA1 pyramidal neurons is the selective trafficking of GluA1-containing receptors to synapses.
A Model for the Interaction between g-8 and CNIH with AMPAR Subunits Figure 8 summarizes the proposed interactions between g-8 and CNIH with surface AMPAR subunits. This model is based primarily on data in which g-8 and CNIH are expressed with the various AMPAR subunits in HEK cells but, as we discuss below, is strongly supported by our data from CA1 pyramidal neurons. We propose based on the I KA /I Glu ratio, a sensitive assay for TARP stoichiometry , that all AMPAR subunit combinations presented in Figure 8 contain four g-8 as shown in HEK cells for AMPAR homomers (Figures 6Aii  and S7 ) and in neurons for AMPAR heteromers ( Figures 1I  and S4C ). The rest of this discussion concerns the number of CNIH proteins associated with the various AMPAR subunit combinations.
GluA1 Homomers
The deactivation of GluA1 homomers in the presence of both g-8 and CNIH in HEK cells is at least as slow as that observed with CNIH alone (Figure 6Ai) . Furthermore, the I KA /I Glu ratio of GluA1 homomers is the same when expressed in HEK cells with only g-8 and when CNIH-2 and g-8 are coexpressed (Figure 6Aii) . Therefore, these receptors must be associated with at least one and possibly four CNIH molecules, in addition to the four g-8 ( Figure 8A ). We cannot be more precise on the CNIH stoichiometry, but g-8 and CNIH-2 are capable of co-occupying GluA1 subunits.
GluA2 Homomers
In HEK cells, based on the same fast kinetics of GluA2 homomers in the presence of both g-8 and CNIH or with g-8 alone ( Figure 6B ), we propose that g-8 prevents GluA2 subunits from associating with CNIH, with GluA2 homomers containing four g-8 and zero CNIH ( Figure 8B ). This model is supported by the ability of hippocampal GluA2A3 receptors to coimmunoprecipitate with g-8 but not CNIH-2 ( Figures 3I and S4D ).
GluA1A2 Heteromers
The fast kinetics seen with this heteromer in the presence of g-8 and CNIH in HEK cells indicate that CNIH has little effect, suggesting the absence of CNIH on this heteromer on the surface ( Figure 6C ). Alternatively, because CNIH does interact with surface GluA1 homomers in the presence of g-8 ( Figure 6A ), CNIH could be associated with GluA1 subunits of surface GluA1A2 heteromers but not affect the kinetics of these heteromers. Wild-type AMPARs in CA1 pyramidal neurons are primarily GluA1A2 ) and exhibit deactivation kinetics characteristic of limited CNIH influence on GluA1A2-gating kinetics ( Figures 4D and 6C ). In the hippocampus, our biochemical data show that CNIH-2 associates exclusively with GluA1A2 receptors through the GluA1 subunit ( Figures 3I and S8B) , and we do observe CNIH-2 on the surface of hippocampal neurons ( Figure 5G ). Because of such data, we would argue that native surface GluA1A2 receptors could have up to two CNIHs associated with the GluA1 subunits but that, if present, they exert no effect on gating kinetics due to g-8's prevention of a functional CNIH association with the GluA2 subunit ( Figure 8C ). If this is the case, CNIH expression in the absence of g-8 should slow the gating kinetics of surface AMPARs in neurons. Indeed, when CNIH-2 is expressed in pyramidal neurons from g-8 KO mice, the gating kinetics of surface AMPARs at synapses are markedly slowed ( Figure 7B ).
GluA2A3 Heteromers
In GluA1 KO mice, the remaining GluA2A3 receptors bind to g-8 and have a high I KA /I Glu ratio, indicating that they also contain four g-8 ( Figures S4C and S4D) . The fast kinetics of native neuronal GluA2A3 receptors in GluA1 conditional KO mice (Figure 4E) , the inability of CNIH-2 KD to influence AMPA EPSCs of neurons from GluA1 KO mice ( Figures 3E and S4B) , and the failure of neuronal GluA2A3 receptors to coimmunoprecipitate CNIH-2 ( Figure 3I ) argue that CNIH is prevented from associating with these receptors. Thus, we assert that GluA2A3 receptors contain four g-8 and zero CNIH molecules ( Figure 8D ). Although speculative, given the likelihood that g-8 inhibits the interaction of CNIH on GluA2 subunits, we believe that g-8 may similarly inhibit CNIH interaction with GluA3.
A B
Tau ( , CNIH-2-overexpressing (OE), g-8 KO, and g-8 KO + CNIH-2 CA1 pyramidal neurons in cultured hippocampal slices: (A), wild-type, 17.4 ± 1.6 pA (n = 8); NexCnih2 À/À , 9.5 ± 0.5 pA (n = 9); CNIH-2 OE, 17.3 ± 1.6 pA (n = 5); g-8 KO, 10.7 ± 0.9 pA (n = 9); and g-8 KO + CNIH-2, 19.1 ± 3.5 pA (n = 7), *p < 0.05; and (B), wild-type, 6.3 ± 0.4 ms (n = 8); NexCnih2 À/À , 4.4 ± 0.3 ms (n = 9); CNIH-2 OE, 6.4 ± 0.4 ms (n = 5); g-8 KO, 7.8 ± 0.6 ms (n = 9); and g-8 KO + CNIH-2, 14.2 ± 0.63 ms (n = 7), *p < 0.05. Select color-matched sample traces are shown above the bar graphs. Sample traces in (B) are peaknormalized. Note that compared to acute slices, baseline mEPSC amplitude is larger, and mEPSC kinetics are faster in slice culture (see Supplemental Experimental Procedures).
CNIH-2/-3 Selectively Interact with GluA1 Subunits and Are Required for Synaptic Expression of GluA1-Containing AMPARs in CA1 Pyramidal Neurons Previous studies, including our own, report little effect of CNIH overexpression on endogenous AMPARs. However, CNIHs clearly interact with AMPARs in heterologous cells and in neurons (Harmel et al., 2012; Shi et al., 2009; Schwenk et al., 2009; Kato et al., 2010a; Gill et al., 2011 Gill et al., , 2012 . To test whether CNIHs have an important role in neurons but are expressed at saturating levels, we performed extensive analyses using genetic deletion and KD of CNIHs. Indeed, we found that deletion of CNIH-2/-3 causes a profound and selective reduction in AMPAR-eEPSC amplitude. This is accompanied by faster decay of mEPSCs, faster deactivation and desensitization of glutamate-evoked currents from somatic patches, and compromised LTP induction. These results demonstrate a critical role for CNIHs in neuronal AMPAR regulation and are particularly fascinating given that the profound synaptic changes seen with the deletion of CNIH-2/-3 match those seen with the selective deletion of GluA1 . Because neurons lacking CNIH proteins look physiologically similar to neurons lacking GluA1, we hypothesized that removal of CNIH-2/-3 might have different effects in various AMPAR KO mice and therefore used these tools to probe CNIH-2 function. Knocking down CNIH-2 in hippocampal slices from GluA2 KO mice causes a profound reduction of AMPAR-eEPSCs, whereas knocking down CNIH-2 in slices from GluA1 KO mice has no effect, either on the amplitude or kinetics of AMPAR EPSCs. These physiological results support a selective action of CNIH-2/-3 on GluA1-containing receptors. We also found that CNIH-2 and GluA1 coimmunoprecipitate with GluA2 when using wild-type hippocampal homogenates. However, in striking contrast, when using homogenates from GluA1 KO mice, CNIH-2 does not coimmunoprecipitate with GluA2. Furthermore, GluA2A3/g-8 receptors, the most likely composition of the receptors remaining in neurons lacking GluA1 or CNIH-2/-3, are twice as fast as GluA1A2/g-8 receptors. Thus, the 50% reduction in mEPSC decay observed in neurons lacking GluA1 and CNIH-2/-3 can be explained by the selective loss of synaptic GluA1-containing AMPARs.
g-8 Prevents the Action of CNIH-2/-3 on Non-GluA1 Subunits Why is the action of CNIH-2/-3 confined to the GluA1 subunit? Previous studies in heterologous systems have shown that CNIH-2 has significant effects on AMPARs containing and lacking GluA1 subunits (Schwenk et al., 2009) . To address this seeming contradiction, we examined the interactions between CNIH-2 and g-8, the most prevalent TARP in the hippocampus (Rouach et al., 2005) , on the kinetics of AMPARs of defined subunit composition. Remarkably, whereas g-8 was incapable of reversing the slowing caused by CNIH-2 on homomeric GluA1 receptors, it fully reversed the slowing caused by CNIH-2 on homomeric GluA2 receptors, revealing exquisite selectivity of CNIH-2 for GluA1 over GluA2 due to g-8 preventing a functional association of CNIH-2 with GluA2. The marked slowing of deactivation is one of the most prominent effects of CNIH-2 on heterologously expressed AMPARs. Does CNIH-2 make any contribution to the kinetics of AMPARs in CA1 pyramidal neurons? As discussed above, the speeding of AMPAR kinetics in neurons lacking CNIH-2/-3 can be fully accounted for by the selective loss of GluA1-containing receptors without any need for a direct action of CNIH-2 on the gating of surface/synaptic AMPARs, raising the question as to whether CNIH-2 is, in fact, associated with surface/synaptic AMPARs. Results from other groups (Gill et al., 2011; Kato et al., 2010a) , based largely on data from heterologous cells, found that CNIH proteins prevent AMPAR resensitization, suggesting that the lack of resensitization in neurons is due to the presence of (A) GluA1 AMPAR subunits simultaneously associate with CNIH proteins and TARP g-8. Therefore, we propose that surface tetrameric GluA1 homomers associate with four g-8 molecules and one to four CNIH molecules. (B) CNIH protein association with GluA2 AMPAR subunits appears to be prevented by g-8. Therefore, in the presence of g-8, we propose that surface GluA2 homomers associate with four g-8 molecules and zero CNIH molecules. (C) Because of GluA1 and GluA2's respective relationships with g-8 and CNIH proteins, we propose that surface GluA1A2 heteromers associate with four g-8 molecules and one to two CNIH molecules. (D) Because GluA1 is required for the physical association of CNIH proteins but not g-8 with AMPARs in neurons, we propose that surface GluA2/3 heteromers associate with four g-8 molecules and zero CNIH molecules. (E) In neurons, CNIH proteins selectively promote the trafficking of GluA1A2 heteromers but not GluA2A3 heteromers to the neuronal surface. g-8 prevents CNIH interaction with non-GluA1 subunits and provides a mechanism for the subunit-specific action of CNIH on GluA1A2 receptor trafficking. Overexpression of CNIH in wild-type neurons does not slow AMPAR-gating kinetics, indicating that CNIH cannot displace g-8 on non-GluA1 subunits. Together, these data suggest a model whereby in the ER/Golgi, g-8 associates with AMPARs prior to CNIH (1), thus limiting subsequent CNIH interactions to only GluA1 subunits, which uniquely associate with both g-8 and CNIH (2). CNIH proteins would then selectively enable the forward trafficking of GluA1A2 heteromers to the neuronal surface (3). CNIH deletion prevents GluA1A2 receptors from leaving the ER/Golgi. CNIH proteins. However, we failed to see resensitization in neurons lacking CNIH proteins ( Figure S3C ). We also found that g-8 reverses the effects of CNIH-2 on the deactivation of GluA1A2 heteromers. Taken together, these findings may leave very little room for a physiologically relevant role for CNIH proteins on synaptic AMPAR gating in neurons and perhaps diminish the relevance of arguments concerning the presence of CNIH proteins on surface AMPARs. However, we do detect the expression of endogenous CNIH on the surface of neurons and are able to observe effects of CNIH-2 on synaptic AMPAR gating in the absence of g-8. Therefore, it is possible for CNIH proteins to associate with synaptic AMPARs. As stated above, such data point to a selective and potentially inert association of CNIH proteins with GluA1 subunits of synaptic GluA1A2 heteromers, with g-8 bound to all four subunits, as previously proposed ).
CNIH-2/-3 Promote Forward Trafficking of GluA1-Containing AMPARs in the ER/Golgi How do CNIH-2/-3 control the level of AMPARs on the surface of hippocampal pyramidal neurons? One possibility is that in the absence of CNIH-2/-3, AMPAR protein is lost, similar to what is seen in g-8 KO mice (Rouach et al., 2005) . However, the modest loss of AMPAR protein seen in the NexCnih2 À/À mice cannot explain the profound loss of surface AMPARs. Rather, our data suggest that the maturation of AMPARs is impaired and that the immature receptors are retained in the ER/cis-Golgi. As pointed out previously , such a role is remarkably similar to the established role of the yeast (Erv14p) and Drosophila (Cni) CNIH homologs, in which these proteins serve as chaperones that aid in the forward trafficking of EGFR ligands from the ER to Golgi (Bö kel et al., 2006; Castillon et al., 2009; Roth et al., 1995) . However, unlike the yeast and Drosophila homologs, but analogous to its effects in HEK cells, CNIH-2 can remain associated with neuronal AMPARs, at least in the absence of g-8 protein.
More specifically, our results indicate that CNIH is essential for the functional expression of GluA1-containing receptors on the surface. Although, at present, we cannot say at what forward trafficking step of these receptors requires CNIH proteins. It is possible that CNIH proteins are required for the transport of GluA1-containing AMPARs from the ER to the Golgi, from the Golgi to the neuronal surface, or both. Future study will undoubtedly be necessary to answer these questions. However, our data would suggest that g-8 proteins associate with AMPARs prior to CNIH proteins as AMPARs progress through the secretory pathway due to g-8 seemingly being required for the subunitspecific actions of CNIH proteins on the surface trafficking of GluA1A2 heteromers ( Figure 8E ).
Our results raise two related issues. First, the delivery of the GluA1 subunit to the surface of CA1 pyramidal neurons requires CNIHs. Yet, this is clearly not the case in heterologous expression systems. What accounts for the difference? The situation may be analogous to TARP g-2, which is essential for the surface delivery of AMPARs in CGNs and greatly facilitates surface delivery of AMPARs in heterologous cells but is not essential for their delivery. Second, can the results obtained in CA1 pyramidal neurons be applied to other neurons? Our results suggest that CNIH-2 plays a similar role in AMPAR trafficking in both dentate granule neurons and layer 2/3 neocortical neurons. However, these neurons are likely to be similar to CA1 neurons in their expression of GluA1A2 heteromers and TARP g-8. Is there an example of a neuron that expresses GluA1 subunits, but not CNIH-2? Our results would suggest not because the surface expression of GluA1 in neurons requires CNIH-2. Also of interest are Purkinje neurons, which express high levels of CNIH-2 but only transiently express GluA1 (Douyard et al., 2007) . It is also worth noting that additional AMPAR auxiliary proteins have been identified, such as CKamp44, which is expressed in DG but not CA1 pyramidal neurons (von Engelhardt et al., 2010) . Whether a functional relationship between CKamp44 and CNIH proteins exists in DG remains to be determined. Another interesting question is whether the ability of CNIH proteins to influence AMPAR gating is utilized in other types of neurons.
Conclusions
Our results reveal an intricate interplay between CNIHs and g-8 that allows for trafficking of GluA1-containing AMPARs to synapses. Because of the selective interaction of CNIHs with GluA1, GluA1A2 heteromers are allowed to dominate the population of neuronal AMPARs in CA1 pyramidal neurons. GluA1A2 heteromers are required for LTP and display slower deactivation kinetics than GluA2A3 heteromers, probably allowing for greater dendritic signal integration. Furthermore, GluA1 subunits possess an intracellular loop and long C tails that are subject to posttranslational modification and protein interactions that have been shown to play roles in activity-dependent synaptic plasticity. It will be of interest to know whether CNIHs themselves are also subject to such forms of regulation and thus contribute to activity-dependent trafficking and function of synaptic GluA1-containing AMPARs. Finally, what is the structural basis that allows CNIH and g-8 to associate with GluA1, whereas for GluA2, g-8 prevents a functional CNIH association? Future work toward a more complete understanding of the uniqueness of GluA1-containing AMPARs and the mechanisms that regulate their function will be invaluable to our understanding of how primary neurons of numerous brain structures communicate with one another. 
Electrophysiology
Acute transverse 300 mm hippocampal slices were prepared from P17-P21 mice. Cultured hippocampal slices were prepared from P6-P9 mice as previously described by Schnell et al. (2002) . Paired recordings of eEPSCs involved simultaneous whole-cell recordings at room temperature from one infected/transfected GFP-positive neuron and a neighboring GFP-negative neuron while stimulating Schaffer collaterals. Series resistance was monitored and not compensated, and cells in which series resistance was above 30 MU or varied by 25% during a recording session were discarded. mEPSCs were recorded in the presence of 0.5 mM TTX. mEPSCs with an amplitude of R5 pA and a rate of rise of R4 pA/ms were automatically detected and analyzed offline with customized software in IGOR. Fast application of 1 mM glutamate to somatic and HEK cell outside-out patches for 1 and 100 ms by a piezoelectric controller (Siskiyou) was used to determine AMPAR deactivation and desensitization kinetics, respectively. Our opentip response experiments show the 20%-80% exchange times to be less than 200 ms.
Western Blotting, Immunoprecipitation, and Glycosidase Treatment Adult mouse hippocampi were homogenized, and the nuclear pellet was removed by centrifugation and resuspended in 1% Triton X-100. Precleared lysates were incubated with antibody-bound Sepharose beads (SigmaAldrich). Beads were washed with lysis buffer and analyzed by immunoblotting with the relevant antibodies as indicated. For glycosylation analysis, the precleared lysate was immunoprecipitated with GluA1 or GluA2 antibody and treated with endoglycosidase Hf (Endo H) or PNGase F overnight at 37 C, resolved by SDS-PAGE, and analyzed by immunoblotting with indicated antibodies.
Surface Immunolabeling/Imaging Hippocampal neurons were cultured on coverslips from E18 rat hippocampus as previously described (Roche and Huganir, 1995) . The neurons were transfected at 7 DIV. Approximately 20 days after transfection, neurons were incubated with GluA1 antibody and then fixed. After blocking, the neurons were incubated with the Alexa Fluor 555-conjugated secondary antibody. The neurons were mounted and imaged under a Zeiss LSM 710 confocal microscope.
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